One such high-potential, yet under-explored therapeutic avenue may rely on inhibition of mycobacterial adhesion to extracellular matrix proteins like fibronectin (Fn), which is important for the initial establishment and later dissemination of infection [7,8,9,10]. The gene discussed is FN1; the disease is infection.